DeviceClearance

MODIFICATION TO LIPOPROTEIN (A) SPQ III ANTIBODY REAGENT SET— 510(k) K001118

Substantially Equivalent

DiaSorin, Inc.

FDA 510(k) clearance K001118 for MODIFICATION TO LIPOPROTEIN (A) SPQ III ANTIBODY REAGENT SET, Substantially Equivalent on 2000-04-25. Applicant: DiaSorin, Inc..

Clearance details

Applicant
DiaSorin, Inc.
Product code
Code DFC
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Ellicott City, MD, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.